Syntara Limited (ASX:SNT)
0.0240
0.00 (0.00%)
Sep 11, 2026, 9:59 AM AEST
Syntara Revenue
In the fiscal year ending June 30, 2026, Syntara had annual revenue of 6.93M AUD, down -5.03%. Syntara had revenue of 3.71M in the half year ending June 30, 2026, a decrease of -27.77%.
Revenue
6.93M
Revenue Growth
-5.03%
P/S Ratio
6.79
Revenue / Employee
n/a
Employees
21
Market Cap
47.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 6.93M | -367.00K | -5.03% |
| Jun 30, 2025 | 7.30M | 1.53M | 26.61% |
| Jun 30, 2024 | 5.76M | -468.00K | -7.51% |
| Jun 30, 2023 | 6.23M | -9.52M | -60.45% |
| Jun 30, 2022 | 15.76M | -7.87M | -33.31% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 131.16M |
| Vita Life Sciences | 96.03M |
| Little Green Pharma | 75.50M |
| Medical Developments International | 42.57M |
| ECS Botanics Holdings | 21.02M |
| IDT Australia | 20.38M |
| Epsilon Healthcare | 13.58M |
| Peak Processing | 12.51M |
Syntara News
- 15 days ago - Syntara Annual report: H2 2026 - Filings
- 6 weeks ago - Syntara Earnings Call Transcript: Q4 2026 - Transcripts
- 6 weeks ago - Syntara Earnings release: Q4 2026 - Filings
- 6 weeks ago - Syntara Slides: Q4 2026 - Filings
- 2 months ago - Syntara Transcript: EGM 2026 - Transcripts
- 3 months ago - Syntara Transcript: Status update - Transcripts
- 3 months ago - Syntara Slides: Status update - Filings
- 4 months ago - Syntara Transcript: Investor update - Transcripts